Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02542072 · ClinicalTrials.gov registry record · NA

Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses

A NA study of Myopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
90
Enrollment target
5
Study locations

NCT02542072 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 90 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02542072, a NA study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to compare the subjective performance of comfilcon A lens against samfilcon A lens after 4 weeks of reusable lens wear.

Conditions Studied

Myopia

Interventions

  • DEVICE comfilcon A
  • DEVICE samfilcon A

Study Locations (5)

California

  • Golden Optometric Group - Whittier

Minnesota

  • Complete Eye Care of Medina - Medina

Bristol

  • Brock & Houlford - Chew Magna

Dorset

  • Tempany's Boutique Opticians - Broadstone

Lancashire

  • David Gould Opticians - Rawtenstall

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2015-08
Est. Completion 2016-03
Phase NA

Sponsor

CooperVision

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02542072

The ClinicalTrials.gov registry entry for NCT02542072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which comfilcon A is the first listed.

NCT02542072 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Minnesota, Bristol.

Frequently Asked Questions

What is clinical trial NCT02542072 about?

NCT02542072 is a clinical study titled "Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses". The purpose of this study is to compare the subjective performance of comfilcon A lens against samfilcon A lens after 4 weeks of reusable lens wear.

What is the current status of trial NCT02542072?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-08. Estimated completion is 2016-03.

What conditions does trial NCT02542072 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT02542072?

The interventions under investigation include: comfilcon A (DEVICE), samfilcon A (DEVICE).

Who is sponsoring clinical trial NCT02542072?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02542072 being conducted?

This trial has 5 study locations across California, Minnesota, Bristol, Dorset, Lancashire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.